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Valorization addendum
Although	 the	 results	 obtained	 in	 these	 feasibility	 studies	 are	 promising,	 one	 could	 doubt	whether	
patients	would	accept	such	an	invasive	and	expensive	procedure	to	treat	their	tinnitus.	
Treatment acceptance
To	reduce	tinnitus	completely,	38%	of	the	197	tinnitus	sufferers	who	attended	a	meeting	of	the	Australian	
Tinnitus	Society	would	accept	(i.e.,	they	indicated	an	acceptance	of	91-100%)	a	CI	as	treatment	option	
while	25%	would	accept	a	CI	in	case	of	reduced	tinnitus	loudness	and	annoyance	by	half.	This	acceptance	
rate	is	comparible	to	noninvasive	wearable	devices	(42%	and	30%,	respectively)	[Tyler,	2012].	In	contrast,	
based	on	a	Dutch	online	survey	on	415	tinnitus	sufferers	and	member	of	the	Dutch	society	for	the	hearing	
impaired,	29%	of	the	population	express	a	large	interest	in	CI	(i.e.,	they	scored	their	acceptance	8-10	on	a	
visual	analogue	scale	from	0	to	10)	in	case	there	is	a	100%	chance	of	full	tinnitus	suppression	while	22%	is	
very	interested	in	case	there	is	a	50%	chance	of	full	tinnitus	suppression.	A	decrease	in	treatment	
acceptability	was	observed	compared	to	the	noninvasive	conventional	hearing	aids,	with	an	acceptance	
rate	of		53%	and	51%	respectively	(unpublished	data).	The	difference	in	CI-acceptance	in	relation	to	
noninvasive	wearable	devices	between	both	studies	can	probably	be	explained	by	selection	bias.	
Nevertheless,	both	studies	have	shown	that	the	acceptance	of	cochlear	implantation	as	a	treatment	
option	for	tinnitus	is	considerable	which	is	consistent	with	the	results	obtained	in	an	American	internet	
survey	with	439	responders.	Here,	almost	three-fourths	of	the	patients	would	be	willing	to	have	a	device	
implanted	in	their	body	for	a	therapy	that	could	eliminate	or	reduce	their	tinnitus	perception	by	half	
[Engineer	et	al.,	2013].				
Economic considerations
As	mentioned	in	the	introduction	of	this	thesis,	tinnitus	affects	about	50	million	people	in	the	United	
States	and	an	estimated	70	million	in	the	European	Union	[Cederroth	et	al.,	2013]	which	is	about	10-15%	
of	the	general	population	[Langguth	et	al.,	2013].	The	estimated	tinnitus	prevalence	in	the	Netherlands	is	
2	million	of	whom	about	60.000	severely	suffer	from	their	tinnitus	[Cima	et	al.	2009].	Furthermore,	Maes	
and	colleagues	[2013]	concluded	that	the	economic	burden	of	tinnitus	to	society	is	substantial	with	an	on	
average	annual	tinnitus	related	societal	cost	per	patient	of	€5,315	in	the	Netherlands.	Most	of	these	costs	
were	associated	with	production	losses;	on	average	€3,702.	Overall,	the	annual	costs	of	tinnitus	in	the	
Netherlands	examined	from	a	societal	perspective	is	about	€6.8	billion	(95%	confidence	interval:	€3.9	
billion	-	€10.8	billion).	The	annual	health	care	costs	were	€1.9	billion	(95%	confidence	interval:	€1.4	billion	
-	€2.5	billion)	which	amounts	to	2.3%	of	the	total	Dutch	health	care	expenditure	[Maes	et	al.,	2013].	
Based	on	these	results	it	is	striking	that	within	the	National	Institute	on	Deafness	and	other	Communication	
Disorders,	tinnitus	funding	accounts	for	only	2%	(about	$5	million	per	year	from	2009	to	2011)	of	total	
hearing	research	funds	[Cederroth	et	al.,	2013].	Private	donors	like	for	example	the	founder	of	the	
Tinnitus	Research	Initiative;	Matteo	de	Nora,	the	fundraising	efforts	of	for	example	the	American	Tinnitus	
Association	and	investments	from	the	industry	are	therefore	essential	for	the	knowledge	about	and	
treatment	options	for	tinnitus.						
Moreover,	Tyler	[2012]	reported	about	the	willingness	to	pay	for	tinnitus	treatments	and	asked	197	
tinnitus	sufferers	to	indicate	how	much	money	they	would	be	willing	to	pay	for	effective	treatments.	Most	
of	these	patients	indicated	to	pay	at	least	$5000	and	20.3%	were	willing	to	pay	as	much	as	$25,000	for	
complete	tinnitus	reduction.	Furthermore,	Engineer	and	colleagues	[2013]	reported	about	an	online	
survey	with	439	responders	of	which	94%	reported	that	they	had	health	insurence.	Here,	almost	40%	had	
already	spent	between	$500	and	$10,000	on	tinnitus	therapies.	Therefore,	from	an	economical	point	of	
view,	the	tinnitus	population	is	an	interesting	market	for	the	industry	with	in	particular	the	industry	of	
medical	devices	as	novel	drugs	take	a	long	time	and	hundreds	of	millions	of	dollars	to	develop.	For	
purposes	of	illustration,	Auris	Medical	recently	invested	$51	million	for	a	phase	3	trial	in	tinnitus	for	the	
pharmacotherapy	using	AM-101	[Cederroth	et	al.,	2013].	In	contrast,	the	average	implantable	medical	
device	takes	about	$10	million	and	five	years	to	develop	[Engineer	et	al.,	2013].		
This	research	project	is	funded	by	one	of	our	CI	industry	partners.	They	are	interested	in	the	long-term	
effects	of	electrical	stimulation	independent	of	environmental	sounds	on	tinnitus	as	they	see	new	
opportunities	to	expand	their	market.	Although	the	highly	sophisticated	CI	shows	promising	results	
concerning	the	tinnitus	suppression,	the	considerable	costs	(about	€25,000	for	the	device	[Broersen,	
2010])	have	hampered	the	clinical	application.	With	the	promising	long-term	effects	of	electrical	
stimulation	independent	of	environmental	sounds	on	tinnitus,	a	“Tinnitus	Implant”	(TI)	should	by	viable.	
This	relatively	simple	neurostimulator	could	be	produced	considerably	cheaper	because	it	does	not	
require	a	strategy	to	encode	environmental	sounds.	This	thesis	includes	feasibility	studies	(Chapter	3-7)	
which	open	new	possibilities	for	the	development	of	this	treatment	option.													
Possible effects on the standard clinical CI
The	results	obtained	on	tinnitus	suppression	may	indirectly	lead	to	future	research	in	order	to	expand	the	
inclusion	criteria	for	CI,	especially	regarding	residual	hearing.	To	date,	there	is	a	considerable	risk	of	
damaged	residual	hearing	due	to	the	implantation	itself,	which	is	the	main	reason	why	only	subjects	who	
were	deaf	in	the	ear	to	be	implanted	were	included.	Changes	in	both	the	device	and	the	surgical	procedure	
could	reduce	this	risk.	If	this	risk	can	be	neglected,	this	treatment	option	could	possibly	be	suitable	for	the	
tinnitus	population	with	significant	residual	hearing.	This	thesis	can	contribute	to	the	interest	to	develop	
an	atraumatic	procedure	for	electrode	insertion.	Although	Chapter	2	of	this	thesis	seems	to	suggest	that	
deterioration	of	residual	hearing	as	a	result	of	the	implantation	itself	does	not	cause	postoperative	
chronic	tinnitus,	hearing	loss	as	a	side	effect	of	the	electrode	insertion	for	tinnitus	treatment	is	
undesirable.			
For	safety	as	well	as	methodological	reasons	the	long-term	effects	of	intracochlear	electrical	stimulation	
independent	of	environmental	sounds	were	investigated	using	the	standard	clinical	CI	which	was	
reprogrammed	to	function	as	a	tinnitus	specific	neurostimulator.	This	gave	us	the	opportunity	to	
additionally	investigate	the	audiological	effects	of	the	standard	CI	in	the	SSD	population	(Chapter	7).	The	
positive	effects	of	CI	obtained	can	contribute	to	the	broadening	of	the	indication	for	the	standard	clinical	
CI.	For	example,	in	Belgium	and	Germany	the	indication	for	CI	is	expanded	already	to	SSD	associated	with	
tinnitus	(the	CI	system	is	CE-Market	for	SSD	in	both	children	and	adults),	because	in	these	countries	the	
value	of	CI	in	SSD	has	been	proven	[Van	de	Heyning	et	al.,	2008;	Kleinjung	et	al.,	2009;	Vermeire	et	al.,	
2009;	Arndt	et	al.,	2010;	Buechner	et	al.,	2010;	Arndt	et	al.,	2011;	Jacob	et	al.,	2011;	Stelzig	et	al.,	2011;	
Hassepass	et	al.,	2012;	Mertens	et	al.,	2013].	It	is	plausible	that	the	Dutch	policy	makers	(College	voor	
Zorgverzekeringen)	will	follow	after	research	in	the	Netherlands	has	reproduced	these	findings.			
Knowledge valorization 
The	findings	and	ideas	have	been	communicated	to	and	shared	with	fellow	researchers	around	the	world	
at	(inter)national	congresses	and	in	scientific	journals.	Furthermore,	a	huge	appreciation	for	our	work	is	
observed	in	the	tinnitus	population.	The	Maastricht	UMC+	organizes	for	example	every	six	months	a	
tinnitus	symposium	in	collaboration	with	the	Dutch	society	for	the	hearing	impaired	(Nederlandse	
Vereniging	Voor	Slechthorenden).	These	symposia	were	always	fully	booked.	Here,	background	
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information	was	given	about	tinnitus	and	hearing	loss	and	recent	findings	from	research	projects	were	
shared.	Frequent	interest	of	national	media	resulted	in	a	generally	better	understanding	of	tinnitus.	As	
tinnitus	remains	refractory	to	current	medical	treatment,	sufferers	are	regularly	disappointed	after	
consulting	a	physician	and	do	often	not	feel	taken	seriously.	This	clinical	research	contributes	to	the	
patient’s	awareness	of	global	developments	in	this	field	of	research.				
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